Madrigal Continues Building Out MASH Pipeline With Ribo Life Science Deal

 
• By Joseph Haas
  
A person going for a handshake with Chinese flag as a background
Madrigal inks a second licensing deal with a Chinese biotech for MASH pipeline assets (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business